MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
MiR-486-5p 通过 p85/AKT 通路靶向 CD133+ 肺癌干细胞
期刊:Pharmaceuticals
影响因子:
doi:10.3390/ph15030297
Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni, Ugo Pastorino, Gabriella Sozzi, Mattia Boeri
发育与干细胞
肺癌
干细胞
PI3K/Akt
Human
CD131
CD133